Doxycycline
Doxycycline is a broad-spectrum tetracycline-class antibiotic used to treat various bacterial infections, including respiratory tract infections, acne, certain sexually transmitted infections, and selected tick-borne diseases. It works by inhibiting bacterial protein synthesis through binding to the 30S ribosomal subunit, thereby preventing bacterial growth. Doxycycline is available in oral formulations such as tablets, capsules, and dispersible tablets, depending on the product. Common side effects include nausea, diarrhoea, and increased sensitivity to sunlight. It may also cause oesophageal irritation if taken with insufficient water or immediately before lying down. Doxycycline is generally avoided during pregnancy and in young children except in specific clinical circumstances where a healthcare professional determines that its benefits outweigh the risks. Appropriate use should follow medical guidance and local prescribing recommendations.
Doxycycline was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Doxycycline, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Doxycycline from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Doxycycline, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
